Robert Williams is a partner and co-head of the UK intellectual property group of Bird & Bird.

He has significant experience in both contentious and non-contentious IP work, advising on the full range of issues relating to patents, copyright, trademarks, designs and trade secrets and confidential information.

Mr Williams has particular experience of complex IP disputes, advising clients from a range of IP-rich industries, including life sciences, energy and utilities, speciality chemicals, mechanical engineering and electronics on strategic IP issues, including life‑cycle management.

He was a member of the teams acting for Pfizer in patent cases concerning Viagra and Lipitor, and acted for Synthon in its action against GSK concerning paroxetine mesylate, which resulted in one of the leading House of Lords judgments on the law of novelty in the United Kingdom.